Association of canine obesity with reduced serum levels of C-reactive protein

Journal of Veterinary Diagnostic Investigation

Volumn 20, Issue 2, 2008, Pages 224-228

  Veiga, Angela P M ^a,b   Price, Christopher A ^b   De Oliveira, Simone T ^a   Dos Santos, Andréa P ^a   Campos, Rómulo ^c   Barbosa, Patricia R ^a   González, Félix H D ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

Acute phase proteins; Dogs; Insulin resistance

Indexed keywords

CANIS FAMILIARIS;

C REACTIVE PROTEIN; CHOLESTEROL; FRUCTOSAMINE; INSULIN; TRIACYLGLYCEROL;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; DOG; DOG DISEASE; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; METABOLISM; NONPARAMETRIC TEST; OBESITY;

ANIMALS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CHOLESTEROL; DOG DISEASES; DOGS; FRUCTOSAMINE; INSULIN; INSULIN RESISTANCE; OBESITY; STATISTICS, NONPARAMETRIC; TRIGLYCERIDES;

EID: 45849130602     PISSN: 10406387     EISSN: None     Source Type: Journal    
DOI: 10.1177/104063870802000214     Document Type: Article

References (27)

1. Appleton DJ, Rand JS, SunvoldGD: 2005, Basal plasma insulin and homeostasis model assessment (HOMA) are indicators of insulin sensitivity in cats. J Feline Med Surg 7:183-193.
2. Bailhache E, Nguyen P, Krempf M, et al.: 2003, Lipoproteins abnormalities in obese and insulin-resistant dogs. Metabolism 52:559-564.
3. Bennet N: 2002, Monitoring techniques for diabetes mellitus in dogs and cats. Clin Tech Small Anim Pract 17:65-69.
4. Bharadwaj D, Stein MP, Volzer M, et al.: 1999, The major receptor of C-reactive protein on leukocyte is Fcγ receptor II. J Exp Med 190:585-590.
5. Coppo JA, Coppo NB: 1997, Serum fructosamine: a reference interval for a heterogeneous canine population. Vet Res Commun 21:471-476.
6. Dandona P, Chaudhuri A, Mohanty P, et al.: 2007, Antiinflammatory effects of insulin. Curr Opin Clin Nutr 10:511-517.
7. Das UN: 2001, Is obesity an inflammatory condition? Nutrition 17:953-963.
8. Faria PF, Araújo DF, Soto-Blanco B: 2005, Glicemia em cães obesos e senis [Glycemia in obese and elderly dogs]. Acta Sci Vet 33:47-50. Abstract in English.
9. Feldman EC, Schall WD, Kruth SA: 1986, Amended insulin/glucose ratio. J Am Vet Med Assoc 188:1227-1230.
10. Feldman EC, Nelson RW: 1996. Canine and feline endocrinology and reproduction, 2nd ed., pp. 422-441. Saunders, Philadelphia, PA.
11. Fransson BA, Karlstam E, Bergstrom A, et al.: 2004, C-reactive protein in the differentiation of pyometra from cystic endometrial hyperplasia/mucometra in dogs. J Am Anim Hosp Assoc 40:391-399.
12. German AJ: 2006, The growing problem of obesity in dogs and cats. J Nutr 136:1940S-1946S.
13. Hoenig M: 2002, Comparative aspects of diabetes mellitus in dogs and cats. Mol Cell Endocrinol 197:221-229.
14. Jesri A, Okonofera EC, Egan BM: 2005, Platelet and white blood cell counts are elevated in patients with metabolic syndrome. J Clin Hypertens 7:705-711.
15. Kaneko JJ: 1997. Clinical biochemistry of domestic animals, 5th ed. Academic Press, New York, NY.
16. Kim SP, Elmerer M, Van Citters G, et al.: 2003, Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by isocaloric moderate-fat diet in the dog. Diabetes 52:2453-2460.
17. Kogika MM, Brandão LP, Jericó MM, et al.: 2001, Determinação das concentrações séricas de glicose e insulina de cães em choque endotóxico [Evaluation of glucose and insulin serum concentration of dogs in endotoxic shock]. Cienc Rural 31:813-817. Abstract in English.
18. Krebs M, Roden M: 2004, Molecular mechanisms of lipid induced insulin resistance in muscle, liver and vasculature. Diabetes Obes Metab 7:621-632.
19. Kuribayashi T, Shimada T, Matsumoto M, et al.: 2003, Determination of C-reactive protein (CRP) in healthy Beagle dogs of various ages and pregnant Beagle dogs. Exp Anim 52:387-390.
20. Laflamme DP: 1997, Development and validation of a body condition score system for dogs. Canine Pract 22:10-15.
21. Martin LJM, Siliart B, Dumon HJW, et al.: 2006, Hormonal disturbances associated with obesity in dogs. J Anim Physiol Anim Nutr 90:355-360.
22. Martínez-Subiela S, Cerón JJ: 2005, Effects of hemolysis, lipemia, hyperbilirrubinemia, and anti-coagulants in canine C-reactive protein, serum amyloid A and ceruloplasmin assays. Can Vet J 46:625-629.
23. Mawbly DI, Bartges JW, d'Avignon A, et al.: 2004, Comparison of various methods for estimating body fat in dogs. J Am Anim Hosp Assoc 40:109-114.
24. McGrotty YL, Knottenbelt CM, Ramsey IK, et al.: 2004, Evaluation of a rapid assay for canine C-reactive protein. Vet Rec 154:175-178.
25. McLaughlin T, Abbasi F, Lamendola C, et al.: 2002, Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 106:2908-2912.
26. Murata H, Shimada N, Yoshioka M: 2004, Current research on acute phase proteins in veterinary diagnosis: an overview. Vet J 68:28-40.
27. Otabe K, Sugimoto T, Jinbo T, et al.: 1998, Physiological levels of C-reactive protein in normal canine sera. Vet Res Commun 22:77-85.